Anaphylactic reaction to radioimmunotherapy despite plasmapheresis to remove anti-mouse antibodies

Ledermann JA , Begent RHJ , Bagshaw KD. Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. Br J Cancer 1988; 58: 654–7.

Kuus-Rachel K , Graver LS , Korawvodin LM. Will immunogenicity limit the use, efficacy and future development of therapeutic monoclonal antibodies. Clin Diagn Lab Immunol 1994; 1: 365–72.

Ledermann JA , Begent RHJ , Maassof C. A phase 1 study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int J Cancer 1991; 47: 659–64.

Zimmer AM , Rosen ST , Spies SM. Radioimmuno therapy of patients with cutaneous T-cell lymphoma using and iodine-131-labelled monoclonal antibody: analysis of retreatment following plasmapheresis. J Nucl Med 1988; 29: 174–80.

Pedley RB , Boden J , Keep PA , Harwood PJ , Green AJ , Rogers GT. Relationship between tumour size and uptake of radiolabelled anti-CEA antibody in a colon tumour xenograft. Eur J Nucl Med 1987; 13: 197–202.

Adam T. Radioiodination for therapy. Ann Clin Biochem 1989; 26(part 3): 244–5.